[Allogeneic unrelated non HLA matched umbilical cord blood transfusion for refractory immune cytopenia: results of a phase I clinical trial].
作者信息
Hu Q L, Han B, He W H, Yang C, Chen M
机构信息
Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 May 14;44(5):431-435. doi: 10.3760/cma.j.issn.0253-2727.2023.05.014.
Abstract
摘要
相似文献
1
[Allogeneic unrelated non HLA matched umbilical cord blood transfusion for refractory immune cytopenia: results of a phase I clinical trial].[异基因非亲缘非HLA配型相合脐带血输注治疗难治性免疫性血细胞减少症：一项I期临床试验结果]
Zhonghua Xue Ye Xue Za Zhi. 2023 May 14;44(5):431-435. doi: 10.3760/cma.j.issn.0253-2727.2023.05.014.
2
3
The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.沙特阿拉伯在接受干细胞移植的范可尼贫血患者中基于氟达拉滨的预处理方案中的经验：与匹配相关的干细胞受者的结果极好，但与无关脐带血干细胞受者的结果不同。
Biol Blood Marrow Transplant. 2012 Apr;18(4):627-32. doi: 10.1016/j.bbmt.2011.08.015. Epub 2011 Aug 24.
4
Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.再生障碍性贫血异基因造血干细胞移植后因移植物失败行脐带血二次移植的结局。
Biol Blood Marrow Transplant. 2017 Dec;23(12):2137-2142. doi: 10.1016/j.bbmt.2017.08.020. Epub 2017 Aug 24.
5
Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.成人患者在接受清髓性双脐带血、匹配同胞供者和匹配无关供者造血细胞移植后的免疫重建。
Biol Blood Marrow Transplant. 2012 Nov;18(11):1664-1676.e1. doi: 10.1016/j.bbmt.2012.06.005. Epub 2012 Jun 12.
6
Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.非血缘供者造血干细胞移植治疗强化预处理方案后成熟淋巴系统恶性肿瘤：脐带血和无关供者外周血造血干细胞移植的结果相似。
Haematologica. 2014 Feb;99(2):370-7. doi: 10.3324/haematol.2013.088997. Epub 2013 Aug 9.
7
[Results of unrelated umbilical cord blood stem cell transplantation for 65 patients in China].[中国65例非亲缘脐血干细胞移植结果]
Zhonghua Er Ke Za Zhi. 2006 Mar;44(3):220-3.
8
Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: current challenges and strategies.脐带血作为造血干细胞移植治疗小儿镰状细胞病的来源：当前的挑战和策略。
Transfus Apher Sci. 2022 Oct;61(5):103554. doi: 10.1016/j.transci.2022.103554. Epub 2022 Aug 29.
9
Combination of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation With Unrelated Cord Blood Unit in Patients Aged 35 to 50 Years With Severe Aplastic Anemia: Preliminary Summary of a Single-Arm Trial.35至50岁重型再生障碍性贫血患者中HLA匹配的同胞异基因造血干细胞移植与无关脐血单位联合应用：单臂试验的初步总结
Transplant Proc. 2019 Dec;51(10):3431-3436. doi: 10.1016/j.transproceed.2019.07.029. Epub 2019 Nov 14.
引用本文的文献
1
Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review.异基因造血干细胞移植后纯红细胞再生障碍性贫血的脐血治疗：病例系列及综述
Front Oncol. 2025 Jun 3;15:1585088. doi: 10.3389/fonc.2025.1585088. eCollection 2025.
2
Umbilical Cord Blood and UC-MSCs Combined with Low-Dose Immunosuppressant in the Treatment of Elderly Patients with Pure Red Cell Aplastic: A Case Series.脐带血和脐带间充质干细胞联合低剂量免疫抑制剂治疗老年纯红细胞再生障碍性贫血：病例系列
Curr Stem Cell Res Ther. 2025;20(3):350-355. doi: 10.2174/011574888X290378240424075002.
本文引用的文献
1
Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.脐带血：同种异体造血干细胞移植和新型细胞治疗应用中被低估和未充分利用的资源。
Curr Opin Hematol. 2022 Nov 1;29(6):317-326. doi: 10.1097/MOH.0000000000000732. Epub 2022 Aug 29.
2
Development of New Drugs for Autoimmune Hemolytic Anemia.自身免疫性溶血性贫血新药的研发
Pharmaceutics. 2022 May 11;14(5):1035. doi: 10.3390/pharmaceutics14051035.
3
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis.自身免疫性溶血性贫血：诊断与鉴别诊断。
Hematol Oncol Clin North Am. 2022 Apr;36(2):315-324. doi: 10.1016/j.hoc.2021.12.001. Epub 2022 Mar 11.
4
Umbilical cord blood transplantation: Still growing and improving.脐带血移植：不断发展和完善。
Stem Cells Transl Med. 2021 Nov;10 Suppl 2(Suppl 2):S62-S74. doi: 10.1002/sctm.20-0495.
5
Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: a systematic review of clinical studies.异体脐带血输注治疗神经疾病的安全性：临床研究的系统评价。
Cytotherapy. 2022 Jan;24(1):2-9. doi: 10.1016/j.jcyt.2021.07.001. Epub 2021 Aug 10.
6
The wider perspective: cord blood banks and their future prospects.更广阔的视角：脐带血库及其未来前景。
Br J Haematol. 2021 Nov;195(4):507-517. doi: 10.1111/bjh.17468. Epub 2021 Apr 20.
7
Applications of Umbilical Cord Derived Mesenchymal Stem Cells in Autoimmune and Immunological Disorders: From Literature to Clinical Practice.脐带间充质干细胞在自身免疫和免疫性疾病中的应用：从文献到临床实践。
Curr Stem Cell Res Ther. 2021;16(4):454-464. doi: 10.2174/1574888X16999201124153000.
8
Regulatory T cell heterogeneity and therapy in autoimmune diseases.调节性 T 细胞异质性及其在自身免疫性疾病中的治疗作用。
Autoimmun Rev. 2021 May;20(5):102715. doi: 10.1016/j.autrev.2020.102715. Epub 2020 Nov 13.
9
The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.调控性 T 细胞的下一个前沿：用于自身免疫性疾病和器官移植的有前景的免疫疗法。
Front Immunol. 2020 Sep 23;11:565518. doi: 10.3389/fimmu.2020.565518. eCollection 2020.
10
A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder.一项评估静脉输注脐带血治疗自闭症谱系障碍儿童的安全性和有效性的 II 期随机临床试验。
J Pediatr. 2020 Jul;222:164-173.e5. doi: 10.1016/j.jpeds.2020.03.011. Epub 2020 May 19.
Zotero 插件